POTTER MYRTLE S 4

What Happened

• Myrtle S. Potter, a director of Guardant Health (GH), sold 1,556 shares in an open-market transaction on June 22, 2026.
• The shares were sold at $131.16 each for a total proceeds of approximately $204,085. This was a sale (transaction code S), which is often routine insider selling and does not by itself indicate company outlook.

Key Details

• Transaction date: 2026-06-22; Filing date (Form 4): 2026-06-23 (filed the next day — appears timely).
• Price per share: $131.16; Shares sold: 1,556; Total value: ~$204,085.
• Shares owned after transaction: not specified in the summary provided — check the full Form 4 (Accession 0001214130-26-000004) for post-transaction holdings.
• Footnotes/plan: sale listed as open-market; no 10b5-1 plan, tax-withholding, or other special footnotes indicated in the provided data.

Context

• Sales by directors can be routine (liquidity, diversification, planned sales) and do not necessarily signal negative company news. Retail investors should view this as a single-data-point and consider broader insider activity and company fundamentals.